AGP Executive Report
Last update: 10 hours agoObesity Drug Debate: New research on semaglutide adds to the case that Ozempic-type weight-loss meds can cut heart attack and stroke risk, while another report highlights the social stigma some users face. Gut Health After Antibiotics: A study finds certain antibiotics can leave detectable changes in the gut microbiome for years—up to 8—raising new questions about long-term effects. Cancer Care Updates: ASCO 2026 coverage includes final long-term results for tivozanib strategies in metastatic renal cell carcinoma, plus other trial readouts pointing to evolving sequencing after immune therapy. Ebola Watch: Health officials in Brazil and Italy are investigating suspected Ebola cases after travelers returned from the DRC and Uganda, as contact tracing strains continue in outbreak zones. NYC Maternal Health: A New York-focused explainer revisits why C-sections remain common and how fetal monitoring can influence decisions. Local Health & Access: New Jersey hospitals expand prostate cancer programs with advanced diagnostics and care pathways, while a New York blood supply alert underscores ongoing community needs. Wellness & Sleep: A guide to drooling and nighttime tips ties symptoms to sleep position, mouth breathing, and childhood development.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
